Broadwood Partners is a Hedge Fund in New York, that has raised $94.68 mm from 83 investors, with a minimum investment of $250.00 k, for an equity fund started in Mar 1989. Data from SEC filing on 8 Dec 2022.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
Former names
BROADWOOD PARTNERS LP
SEC CIK
AUM ?
$1.85 bn
Address
Broadwood Partners
BROADWOOD CAPITAL INC.
724 FIFTH AVENUE, 9TH FLOOR
NEW YORK
NY 10019
BROADWOOD CAPITAL INC.
724 FIFTH AVENUE, 9TH FLOOR
NEW YORK
NY 10019
Phone
212-508-5735
Ownership
| Fund structure | AUM | Fund type |
|---|---|---|
| Broadwood Capital, Inc | $1.85 bn | |
| Broadwood Partners, L.P. | $1.85 bn | Hedge Fund |
Latest filings (excl ownership)
D/A
Indefinite amount in investment fund / equity, sold $94.68 mm, 83 investors
8 Dec 22
D/A
Indefinite amount in investment fund / equity, sold $85.92M, 79 investors
9 Dec 21
D/A
Indefinite amount in investment fund / equity, sold $77.38M, 73 investors
11 Dec 20
D/A
Indefinite amount in investment fund / equity, sold $68.38M, 71 investors
8 Jan 20
D/A
Indefinite amount in investment fund / equity, sold $66.17M, 70 investors
8 Jan 19
D/A
Indefinite amount in investment fund / equity, sold $63.66M, 68 investors
8 Jan 18
D/A
Indefinite amount in investment fund / equity, sold $58.3M, 63 investors
6 Jan 17
D/A
Indefinite amount in investment fund, sold $56.98M, 63 investors
11 Jan 16
D/A
Indefinite amount in investment fund, sold $51.37M, 59 investors
12 Jan 15
D/A
Indefinite amount in investment fund, sold $49.67M, 58 investors
14 Jan 14
Latest ownership filings
4
NEAL C BRADSHER
29 Dec 22
13F-NT
Notice of holdings reported by another manager
10 Nov 22
13F-NT
Notice of holdings reported by another manager
15 Aug 22
SC 13D/A
Oncocyte Corp
28 Jul 22
13F-NT
Notice of holdings reported by another manager
16 May 22
4
NEAL C BRADSHER
15 Apr 22
SC 13D/A
Oncocyte Corp
15 Apr 22
4
NEAL C BRADSHER
25 Mar 22
SC 13D/A
Lineage Cell Therapeutics, Inc.
25 Mar 22
13F-NT
Notice of holdings reported by another manager
14 Feb 22